SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity

Autor: Muriel Aguilar-Bretones, Yvette den Hartog, Laura L. A. van Dijk, S. Reshwan K. Malahe, Marjolein Dieterich, Héctor Tejeda Mora, Yvonne M. Mueller, Marion P. G. Koopmans, Marlies E. J. Reinders, Carla C. Baan, Gijsbert P. van Nierop, Rory D. de Vries, RECOVAC Consortium

Publikováno v: npj Vaccines, Vol 9, Iss 1, Pp 1-13 (2024)

Abstract Healthy individuals with hybrid immunity, due to a SARS-CoV-2 infection prior to first vaccination, have stronger immune responses compared to those who were exclusively vaccinated. However, little is known about the characteristics of antib

Externí odkaz: https://doaj.org/article/48df249ea6e345f7b80f0b5706f5fa07

Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients

Autor: S. Reshwan K. Malahe, Jeroen J. A. van Kampen, Olivier C. Manintveld, Rogier A. S. Hoek, Caroline M. den Hoed, Carla C. Baan, Marcia M. L. Kho, Georges M. G. M. Verjans

Publikováno v: Viruses, Vol 15, Iss 7, p 1595 (2023)

Solid organ transplant recipients (SOTRs) are at high risk of human herpesvirus (HHV)-related morbidity and mortality due to the use of immunosuppressive therapy. We aim to increase awareness and understanding of HHV disease burden in SOTRs by provid

Externí odkaz: https://doaj.org/article/91d7a301a5834d7db4ecdb3972ab81be

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC)

Autor: Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, Priya Vart, Daryl Geers, Rory D de Vries, Corine H GeurtsvanKessel, Carla C Baan, Renate G van der Molen, Dimitri A Diavatopoulos, Ester B M Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P J de Vries, Ron T Gansevoort, Frederike J Bemelman, Marlies E J Reinders, Jan-Stephan F Sanders, Luuk B Hilbrands, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc A.G.J. ten Dam, Lennert Gommers, Dorien Standaar, Marieke van der Heiden, Yvonne M.R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria H.L.A. Philipsen, Djenolan van Mourik, Susanne Bogers, Laura L.A. van Dijk, Nynke Rots, Gaby Smits, Marjan Kuijer, Marc H. Hemmelder

Publikováno v: Lancet Infectious Diseases, 23, 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319

BACKGROUND: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e83aaaad3fb6c01d134e2f61f346dd
https://pure.eur.nl/en/publications/7c01b0ca-5480-4d2b-acfb-2834cc7589ba

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Autor: Priya Vart, Wouter B Mattheussens, Marion Koopmans, Gerco den Hartog, Dimitri A. Diavatopoulos, Luuk B. Hilbrands, Marlies E J Reinders, Djenolan van Mourik, Renate G. van der Molen, Celine Imhof, Marieke van der Heiden, Daryl Geers, C. Baan, Frederike J. Bemelman, Rory D. de Vries, Marcia M L Kho, S Reshwan K Malahe, Debbie van Baarle, Rob van Binnendijk, Ester B. M. Remmerswaal, Jan-Stephan F. Sanders, Corine H. GeurtsvanKessel, Ron T. Gansevoort, Nynke Y. Rots, A. Lianne Messchendorp, Sophie C Frölke

Publikováno v: Transplantation, 106(4), 821-834. Lippincott Williams & Wilkins
Transplantation, 106(4), 821-834. Lippincott Williams and Wilkins
Transplantation, 106(4), 821-834. LIPPINCOTT WILLIAMS & WILKINS
Transplantation, 106, 821-834
Transplantation, 106, 4, pp. 821-834

BACKGROUND: In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of COVID-19 vaccination in different cohorts of kidney patients and a co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e23dbd02e3411151f1942b9887b11a
https://hdl.handle.net/2066/248732

Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study

Autor: S Reshwan K, Malahe, Rogier A S, Hoek, Virgil A S H, Dalm, Annoek E C, Broers, Caroline M, den Hoed, Olivier C, Manintveld, Carla C, Baan, Charlotte M, van Deuzen, Grigorios, Papageorgiou, Hannelore I, Bax, Jeroen J, Van Kampen, Merel E, Hellemons, Marcia M L, Kho, Rory D, de Vries, Richard, Molenkamp, Marlies E J, Reinders, Bart J A, Rijnders

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In the general population, illness after infection with the SARS-CoV-2 Omicron variant is less severe compared with previous variants. Data on the disease burden of Omicron in immunocompromised patients are lacking. We investigated the clinical chara

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d9a1331f3dbbec1b36ab103f139b5ec5
https://pubmed.ncbi.nlm.nih.gov/35869843